Tag:
Novozymes
Latest Headlines
Latest Headlines
Repligen shares tank on expected FDA rejection
Repligen put out the word this morning that the FDA has cancelled an expert panel review of its pancreatic imaging agent.
Repligen snags Novozymes business in $28.3M deal
Repligen has made a move to boost its biomanufacturing capacity and its commercial prospects. The Waltham, MA-based biotech says it grabbed Novozymes Biopharma Sweden for $22.7 million (€17
